|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02480 LUZHU BIOTECH-B
Nominal 
13.600 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (129,046) | (86,085) | (189,948) | (77,265) |
| Net Cash from / (used in) Investing Activities | -- | (124,654) | (47,583) | 98,581 | (223,262) |
| Net Cash from / (used in) Financing Activities | -- | 155,301 | 14,889 | 273,171 | 336,978 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (98,399) | (118,779) | 181,804 | 36,451 |
| Cash & Cash Equivalents at beginning of period | -- | 140,126 | 257,891 | 68,976 | 32,030 |
| Effect of Foreign Exchange Rate Changes | -- | (1,540) | 1,014 | 7,111 | 495 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 40,187 | 140,126 | 257,891 | 68,976 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -61,622 |
| %Change | -20.559% |
| EPS / (LPS) | RMB -0.310 |
| NBV Per Share (¥) | RMB 3.009 |